Flaxseed, the richest known source of plant lignans, has been shown to have
chemoprotective effects in animal and cell studies. Some of its effects ma
y be mediated through its influence on endogenous hormone production and me
tabolism Two competing pathways in estrogen metabolism involve production o
f the 2-hydroxylated and 16 alpha-hydroxylated metabolites. Because of the
proposed differences in biological activities of these metabolites, the bal
ance of the two pathways has been used as a biomarker for breast cancer ris
k. We examined the effects of flaxseed consumption on urinary estrogen meta
bolite excretion in postmenopausal women. Twenty-eight postmenopausal women
were studied for three seven-week feeding periods in a randomized crossove
r design. During the feeding periods, subjects consumed their usual diets p
lus ground flaxseed (0, 5, or 10 g/day). Urinary excretion of the estrogen
metabolites 2-hydroxyestrogen (2-OHEstrogen) and 16 alpha-hydroxyestrone (1
6 alpha-OHE1) as well as their ratio, 2/16 alpha-OHE1, was measured by enzy
me immunoassay. Flaxseed supplementation significantly increased urinary 2-
OHEstrogen excretion (p < 0.0005) and the urinary 2/16 alpha-OHE1 ratio (p
< 0.05) in a linear, dose-response fashion. There were no significant diffe
rences in urinary 16 alpha-OHE1 excretion. These results suggest that flaxs
eed may have chemoprotective effects in postmenopausal women.